Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
Filter
Medientyp
Sprache
Region
Bibliothek
Erscheinungszeitraum
Fachgebiete(RVK)
Zugriff
  • 1
    Online-Ressource
    Online-Ressource
    New York, NY : Springer Science+Business Media, LLC
    UID:
    gbv_1651286248
    Umfang: Online-Ressource (XIII, 212p. 29 illus., 18 illus. in color, digital)
    Ausgabe: 1
    ISBN: 9781461402046
    Serie: Advances in Experimental Medicine and Biology 719
    Inhalt: Andrew J. Pollard
    Inhalt: This book covers course with topics in infectious diseases in children and is intended for Pediatric Infectious disease clinical researchers, trainees, trainers, and all those who manage the research of children with infections and the children themselves. The conference is being supported by several societies and is sponsored by several pharmaceutical companies, such as Aventis, Baxter, Chiron Vaccines, Wyeth, etc. ToC reflects the scientific program found at our associated website
    Anmerkung: Description based upon print version of record , Hot Topics in Infection and Immunity in Children VIII; Preface; Acknowledgments; Contents; Contributors; Our Time of Pestilence: Purchasing Immunity and Ignoring the Misery of Others; 1 Prisoners of Life; 2 Purchasing Health; 3 The Deceptive Language of Risk; 3.1 The Obesity Epidemic; 3.2 Influenza and Pandemic Risk; 4 Beware the Forecast Epidemic; References; Neonatal Meningitis: Can We Do Better?; 1 Incidence; 2 Aetiology; 3 Mortality and Morbidity; 4 Presentation; 5 Diagnosis; 5.1 Should an LP Only Be Performed on Symptomatic Babies? , 5.2 Should an LP Be Performed Only When Blood Cultures are Positive?5.3 Making the Diagnosis; 5.4 Other Diagnostic Issues; 5.5 Does a Delay in the Laboratory Evaluation of the CSF Affect the Results?; 5.6 What Influences the Success of Obtaining an LP?; 6 Management; 6.1 Empiric Antibiotics; 6.2 Empiric Cover for Listeria Infection; 7 What are the Predictors for a Poor Outcome?; 8 Improving the Outcome of Neonatal Meningitis; 8.1 What is the Role of New or Different Antibiotics in the Management of Neonatal Bacterial Meningitis? , 8.2 What is the Role of Other Adjunctive Therapy in the Management of Bacterial Meningitis?8.2.1 What is the Role of Immunoglobulin in Neonatal Bacterial Sepsis/Meningitis?; 8.2.2 G- or GM: CSF; 8.2.3 The Use of Corticosteroids in Meningitis; 8.2.4 What About Oral Glycerol?; 9 Prevention; 10 Conclusions; 10.1 Improving the Outcome of Neonatal Meningitis…Can We Do Better?; References; Approaches Towards Avoiding Lifelong Antiretroviral Therapy in Paediatric HIV Infection; 1 Introduction; 2 How does Paediatric HIV Infection Differ from Adult Infection? , 2.1 Rate of Disease Progression, Timing of Infection2.2 Immune Activation and HIV Disease Progression; 2.3 Control of HIV viraemia; 2.4 Thymic Activity; Immune Reconstitution on ART; 3 CD8+ T-Cell Mediated Immune Control of HIV; 3.1 CD8+ T-Cell Mediated Immune Control of HIV in Adults; 3.2 CD8+ T-Cell Mediated Immune Control of HIV in Children; 4 ART Interruption Studies; 4.1 ART Interruption Studies in HIV-Infected Adults; 4.2 ART Interruption Studies in HIV-Infected Children; 5 Conclusion; References; How Short Is Long Enough for Treatment of Bone and Joint Infection?; 1 Introduction , 2 Role of Antimicrobials3 Risk of Reoccurrence; 4 Monitoring the Course of OM, SA, and OMSA; 5 Towards Shorter Antimicrobial Courses; 6 Lessons Learned from Prospective Studies in OM, SA, and OMSA; References; What's New in Diagnostic Testing and Treatment Approaches for Mycoplasma pneumoniae Infections in Children?; 1 Introduction; 2 Epidemiology of Mycoplasma Respiratory Infections; 3 Clinical Presentation and Basis for Pathogenesis; 3.1 Respiratory Disease; 3.2 Extrapulmonary Manifestations; 4 Diagnostic Approach; 4.1 Culture; 4.2 Serology; 4.3 Nucleic Acid Amplification Tests , 5 Macrolide Resistance and Treatment Alternatives
    Weitere Ausg.: ISBN 9781461402039
    Weitere Ausg.: Buchausg. u.d.T. ISBN 9781461402039
    Sprache: Englisch
    Fachgebiete: Medizin
    RVK:
    URL: Volltext  (lizenzpflichtig)
    URL: Cover
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 2
    Buch
    Buch
    New York, NY [u.a.] : Springer
    UID:
    kobvindex_ZLB15433703
    Umfang: XIII, 212 Seiten , Ill., graph. Darst.
    ISBN: 9781461402039
    Serie: Advances in experimental medicine and biology 719
    Sprache: Englisch
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 3
    UID:
    almahu_9949419364202882
    Umfang: XIII, 212 p. 29 illus., 18 illus. in color. , online resource.
    Ausgabe: 1st ed. 2011.
    ISBN: 9781461402046
    Serie: Advances in Experimental Medicine and Biology, 719
    Inhalt: Book covers course with topics in infectious diseases in children and is intended for Pediatric Infectious disease clinical researchers, trainees, trainers, and all those who manage the research of children with infections and the children themselves. The conference is being supported by several societies and is sponsored by several pharmaceutical companies, such as Aventis, Baxter, Chiron Vaccines, Wyeth, etc. ToC reflects the scientific program found here: http://www.oxfordiic.org/#course.
    Anmerkung: Our time of pestilence: purchasing immunity and ignoring the misery of others -- Neonatal meningitis: can we do better? -- Approaches towards avoiding lifelong antiretrovial therapy in paediatric HIV infection -- How short is long enough for treatment of bone and joint infection? -- What's new in diagnostic testing and treatment approaches for Mycoplasma pneumoniae infections in children? -- Pigs, poultry, and pandemic influenza: how zoonotic pathogens threaten human health -- Kingella kingae infections in children: an update -- Influenza pandemics -- Management of shunt related infections -- Nontuberculous lymphadenopathy in children: using the evidence to plan optimal management -- Pediatric brucellosis: an (almost) forgotten disease -- Q fever: still more queries than answers -- Rickettsioses in children: a clinical approach -- What is the evidence behind recommendations for infection control? -- What do we know about how to treat tuberculosis? -- Bacterial meningitis in childhood -- Mycobacterium marinum infection.
    In: Springer Nature eBook
    Weitere Ausg.: Printed edition: ISBN 9781461402053
    Weitere Ausg.: Printed edition: ISBN 9781461402039
    Weitere Ausg.: Printed edition: ISBN 9781493952243
    Sprache: Englisch
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Meinten Sie 9781461400394?
Meinten Sie 9781461302339?
Meinten Sie 9781461400059?
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie auf den KOBV Seiten zum Datenschutz